Autoantibodies in systemic sclerosisSTEEN, Virginia D.Seminars in arthritis and rheumatism. 2005, Vol 35, Num 1, pp 35-42, issn 0049-0172, 8 p.Article

SclerodermaSTEEN, Virginia D.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, 294 p.Serial Issue

Scleroderma renal crisisSTEEN, Virginia D.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, vii, 315-333 [20 p.]Article

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementSTEEN, Virginia; MEDSGER, Thomas A.Arthritis and rheumatism. 2003, Vol 48, Num 2, pp 516-522, issn 0004-3591, 7 p.Article

Immunopathogenesis of systemic sclerosisWHITE, B.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, vi, 695-708 [15]Article

Antinuclear antibody in systemic sclerosis (scleroderma)OKANO, Y.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, vi, 709-735 [28 p.]Article

Long-term outcomes of scleroderma renal crisisSTEEN, Virginia D; JR., Thomas A.Annals of internal medicine. 2000, Vol 133, Num 8, pp 600-603, issn 0003-4819Article

Clinical problems : The lungsSILVER, R. M.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, viii, 825-840 [17 p.]Article

Improvement in skin thickening in systemic sclerosis associated with improved survivalSTEEN, Virginia D; MEDSGER, Thomas A.Arthritis and rheumatism. 2001, Vol 44, Num 12, pp 2828-2835, issn 0004-3591Conference Paper

Changes in causes of death in systemic sclerosis, 1972-2002STEEN, Virginia D; MEDSGER, Thomas A.Annals of the rheumatic diseases. 2007, Vol 66, Num 7, pp 940-944, issn 0003-4967, 5 p.Article

Severe organ involvement in systemic sclerosis with diffuse sclerodermaSTEEN, Virginia D; MEDSGER, Thomas A.Arthritis and rheumatism. 2000, Vol 43, Num 11, pp 2437-2444, issn 0004-3591Article

Scleroderma epidemiologyMAYES, M. D.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, pp vi-vii, issn 0889-857X, 16 p.Article

Systemic sclerosis : A vascular perspectiveLEROY, E. C.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, pp v-vi, issn 0889-857X, 22 p.Article

Scleroderma renal crisisSTEEN, V. D.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, viii, 861-878 [19 p.]Article

Treatment of systemic sclerosisPOPE, J. E.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, ix, 893-907 [16 p.]Article

Cardiac involvement in sclerodermaDESWAL, A; FOLLANSBEE, W. P.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, viii, 841-860 [21 p.]Article

Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibodySTEEN, Virginia D; LUCAS, Mary; FERTIG, Noreen et al.Journal of rheumatology. 2007, Vol 34, Num 11, pp 2230-2235, issn 0315-162X, 6 p.Article

Pathogenesis of scleroderma : CollagenJIMENEZ, S. A; HITRAYA, E; VARGA, J et al.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, v, 647-674 [29 p.]Article

Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): Baseline Characteristics and Description of Study PopulationHINCHCLIFF, Monique; FISCHER, Aryeh; SCHIOPU, Elena et al.Journal of rheumatology. 2011, Vol 38, Num 10, pp 2172-2179, issn 0315-162X, 8 p.Article

Raynaud's phenomenonWIGLEY, F. M; FLAVAHAN, N. A.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, vii, 765-781 [18 p.]Article

Occupational and environmental influences on sclerodermaSILMAN, A. J; HOCHBERG, M. C.Rheumatic diseases clinics of North America. 1996, Vol 22, Num 4, issn 0889-857X, vi, 737-749 [14 p.]Article

High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial: Lessons learnedCLEMENTS, Philip J; SEIBOLD, James R; STEEN, Virginia et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 4, pp 249-263, issn 0049-0172, 15 p.Article

Registries in systemic sclerosis: a worldwide experienceGALLUCCIO, Felice; WALKER, Ulrich A; NASH, Peter et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 60-68, issn 1462-0324, 9 p.Article

Combination of Echocardiographic and Pulmonary Function Test Measures Improves Sensitivity for Diagnosis of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: Analysis of 2 CohortsGLADUE, Heather; STEEN, Virginia; KHANNA, Dinesh et al.Journal of rheumatology. 2013, Vol 40, Num 10, pp 1706-1711, issn 0315-162X, 6 p.Article

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Type I Collagen Treatment in Patients With Diffuse Cutaneous Systemic Sclerosis I. Oral Type I Collagen Does Not Improve Skin in All Patients, but May Improve Skin in Late-Phase DiseasePOSTLETHWAITE, Arnold E; WENG KEEWONG; MORELAND, Larry et al.Arthritis and rheumatism. 2008, Vol 58, Num 6, pp 1810-1822, issn 0004-3591, 13 p.Article